|
Market Closed -
Saudi Arabian S.E.
09:49:56 2026-10-07 EDT
|
5-day change | 1st Jan Change | ||
| 64.15 SAR | +0.47% |
|
+1.58% | +0.96% |
| 10-07 | Avalon Pharma, Aurisco to Cooperate on Oligonucleotide Manufacturing in Saudi Arabia | MT |
| 09-17 | Avalon Pharma Renews SAR104 Million Bank Facility Deal with Banque Saudi Fransi | MT |
Chart calendar Middle East Pharmaceutical Industries Company
Upcoming events on Middle East Pharmaceutical Industries Company
No events available
Past events on Middle East Pharmaceutical Industries Company
| 2026-05-11 | Extraordinary General Meeting | 11:30 |
| 2026-05-11 | Présentation aux Actionnaires / Analystes | 11:30 |
| 2026-04-09 | Annual General Meeting | 11:30 |
Past dividends on Middle East Pharmaceutical Industries Company
| 2026-09-02 | Ex-dividend date - 0.8 SAR | 00:00 |
| 2026-05-12 | Significant Split/Dividend | 00:00 |
| 2026-03-30 | Ex-dividend date - 1.32 SAR | 00:00 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 |
|---|---|---|---|---|
|
Net sales Million SAR | Released Forecast Spread | 338 334 1.33% | 394 385 2.34% | 460 464 -0.76% |
|
EBITDA Million SAR | Released Forecast Spread | 91,7 96,0 -4.5% | 0,00 0,00 - | 128 133 -3.44% |
|
EBIT Million SAR | Released Forecast Spread | 78,3 82,0 -4.57% | 91,0 97,0 -6.15% | 108 114 -4.9% |
|
Earnings before Tax (EBT) | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
|
Net income | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
|
EPS | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
| Announcement Date | 25/03/24 | 27/03/25 | 04/03/26 |
Quarterly results
| Fiscal Period | June | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 |
|---|---|---|---|---|---|---|---|---|
|
Net sales Million SAR | Released Forecast Spread | 136 140 -2.87% | 97,4 | 118 115 2.31% | 138 141 -2.47% | 130 105 23.93% | 136 134 1.85% | |
|
EBIT Million SAR | Released Forecast Spread | 47,2 54,3 -13% | 28,3 30,0 -5.8% | 46,8 48,8 -4.03% | 30,7 25,1 22.39% | 34,2 31,5 8.44% | ||
|
Net income Million SAR | Released Forecast Spread | 8,28 | ||||||
|
EPS SAR | Released Forecast Spread | 0,23 | ||||||
| Announcement Date | 27/03/25 | 18/05/25 | 10/08/25 | 11/11/25 | 04/03/26 | 12/05/26 | 06/08/26 |
| 2026-10-11 |  | Board of Directors Meeting | |
| 2026-10-14 | | Extraordinary General Meeting | 04:00 |
| 2026-10-15 | | Extraordinary General Meeting | 03:30 |
| 2026-10-19 | | Extraordinary General Meeting | 03:30 |
| 2026-10-26 | | Earnings release - Q2 2027 | |
| 2026-10-26 | | Board of Directors Meeting | |
| 2026-10-26 | | Earnings release - Q3 2026 | |
| 2026-10-27 | | Earnings release - Q3 2026 | |
| 2026-10-27 | | Earnings release - Q3 2026 | |
| 2026-10-27 | | Earnings release - Q3 2026 |
Past sector events for Middle East Pharmaceutical Industries Company
| 2026-10-07 | | Ex-dividend date - 2.32 ZAR | 00:00 |
| Today | | Earnings presentation | 23:00 |
| 2026-10-02 | | Ex-dividend date for special dividend - 0.995 HKD | 00:00 |
| 2026-09-30 | | Board of Directors Meeting | |
| 2026-09-30 | | Présentation aux Actionnaires / Analystes | 03:00 |
| 2026-09-30 | | Annual General Meeting | 03:00 |
| 2026-09-29 | | Ex-dividend date - 40 JPY | 00:00 |
| 2026-09-29 | | Ex-dividend date - 25 JPY | 00:00 |
| 2026-09-28 | | Board of Directors Meeting | 09:11 |
| 2026-09-25 | | Extraordinary General Meeting |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
- Stock Market
- Stocks
- 4016 Stock
- Calendar Middle East Pharmaceutical Industries Company
Select your edition
All financial news and data tailored to specific country editions
